Unusual combination therapy shows promise for preventing prostate cancer, researchers find

September 17, 2013

Combining a compound from broccoli with an antimalarial drug prevents prostate cancer in mice, University of Pittsburgh Cancer Institute (UPCI) researchers discovered.

The National Cancer Institute-funded research will be published in the Oct. 1 issue of the journal Cancer Research. It is the first such study to show the effectiveness of the combined treatment and provides compelling evidence for human clinical trials.

"Men with prostate cancer suffer significant impairments in , not only from the disease itself, but also from the treatments," said senior author Shivendra Singh, Ph.D., professor in Pitt's Department of Pharmacology & Chemical Biology. "Because the predominant risk factors for prostate cancer, such as age, race and genetics, cannot be avoided, there is a great need for preventative treatments for those most at risk."

Cruciferous vegetables, such as , watercress and cabbage, are associated with a lower risk of prostate cancer. The phytochemical sulforaphane in cruciferous vegetables is believed to be responsible.

When scientists tested sulforaphane in the lab, they found it works to prevent early-stage prostate cancer, but not late-stage. Dr. Singh and his colleagues hypothesized that this was due to a cellular mechanism called autophagy, which limits the ability of drugs to destroy cancer.

The chloroquine inhibits autophagy. When chloroquine and sulforaphane were given to mice predisposed to prostate cancer, only 12 percent of the mice developed late-stage prostate cancer, compared to half in the control group.

"These results are very promising, but I do not recommend that men take chloroquine while eating broccoli in an attempt to prevent prostate cancer," said Dr. Singh. "Certainly eating broccoli and other cruciferous vegetables is good for you, but chloroquine can have side effects, and it has not been tested in humans for the purpose of preventing ."

Explore further: Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables

More information: cancerres.aacrjournals.org/content/early/2013/08/06/0008-5472.CAN-13-0755.abstract

Related Stories

Recommended for you

Researchers identify new target for cancer immunotherapy

January 17, 2017

Massachusetts General Hospital investigators have found new evidence that the tumor necrosis factor receptor type II (TNFR2) may be a major target for immuno-oncology treatments, which induce a patient's immune system to ...

Study reveals why cancer cells spread within the body

January 17, 2017

Each day, more than 1,600 people die from cancer in the US, and 450 in the UK, mostly because the disease has spread beyond a stage when surgery is an effective cure and has become resistant to therapy. Despite decades of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.